Status:
UNKNOWN
S-1-induced Lacrimal Drainage Obstruction
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
S-1 is an effective drug in gastric cancer (GC) for palliative chemotherapy in Eastern and Western patients. Recently, S-1 has been also reported to be an effective adjuvant therapy for GC patients wh...
Eligibility Criteria
Inclusion
- Patients who received curative (R0) surgery for GC
- Patients receiving adjuvant S-1 chemotherapy
- Patients with adequate major organ functions for chemotherapy
- Patient who have taken S-1 at least 7 days (for blood and tear sampling)
Exclusion
- Patients who are not candidate for adjuvant S-1 chemotherapy
- Patients with previous history of LDO
- Patients with other opthalmologic disease who are not appropriate to be included in this study (i.e., patients using eyedrop medication; patients with dry eye whose tears cannot be sampled)
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01486472
Start Date
November 1 2010
End Date
December 1 2013
Last Update
December 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 463-707